Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
Fernando
Lecanda Cordero
Profesional Investigador
Publicacions en què col·labora amb Fernando Lecanda Cordero (5)
2022
-
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer
Cancer Discovery, Vol. 12, Núm. 5, pp. 1356-1377
2021
-
Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group
Radiotherapy and Oncology, Vol. 154, pp. 128-134
2018
-
Erratum: Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial (Brachytherapy (2018) 17(5) (734–741), (S1538472118300898) (10.1016/j.brachy.2018.04.007))
Brachytherapy
-
Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial
Brachytherapy, Vol. 17, Núm. 5, pp. 734-741
2017
-
EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
Journal of Hematology and Oncology, Vol. 10, Núm. 1, pp. 1-12